Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.36822376 |
2 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.22562542 |
3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.99904557 |
4 | ATP synthesis coupled proton transport (GO:0015986) | 5.99904557 |
5 | respiratory electron transport chain (GO:0022904) | 5.41271482 |
6 | electron transport chain (GO:0022900) | 5.28141007 |
7 | protein neddylation (GO:0045116) | 4.83452497 |
8 | central nervous system myelination (GO:0022010) | 4.41611373 |
9 | axon ensheathment in central nervous system (GO:0032291) | 4.41611373 |
10 | fatty acid elongation (GO:0030497) | 4.31639297 |
11 | sequestering of actin monomers (GO:0042989) | 4.06523027 |
12 | chaperone-mediated protein transport (GO:0072321) | 3.81245005 |
13 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.67310653 |
14 | hydrogen ion transmembrane transport (GO:1902600) | 3.62421315 |
15 | viral protein processing (GO:0019082) | 3.49275564 |
16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.43821856 |
17 | signal peptide processing (GO:0006465) | 3.43350862 |
18 | protein maturation by protein folding (GO:0022417) | 3.40500446 |
19 | aldehyde catabolic process (GO:0046185) | 3.39758067 |
20 | protein complex biogenesis (GO:0070271) | 3.38530627 |
21 | proton transport (GO:0015992) | 3.36483015 |
22 | viral transcription (GO:0019083) | 3.34520581 |
23 | response to interferon-beta (GO:0035456) | 3.34115827 |
24 | hydrogen transport (GO:0006818) | 3.29327080 |
25 | neutrophil activation involved in immune response (GO:0002283) | 3.28193175 |
26 | amyloid precursor protein metabolic process (GO:0042982) | 3.27308526 |
27 | amyloid precursor protein catabolic process (GO:0042987) | 3.24887526 |
28 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.20132149 |
29 | NADH dehydrogenase complex assembly (GO:0010257) | 3.20132149 |
30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.20132149 |
31 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.20064031 |
32 | phagosome maturation (GO:0090382) | 3.17622753 |
33 | ATP biosynthetic process (GO:0006754) | 3.16895784 |
34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.12059924 |
35 | nucleotide transmembrane transport (GO:1901679) | 3.09902728 |
36 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.08619337 |
37 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.07344355 |
38 | translational termination (GO:0006415) | 3.07307087 |
39 | platelet dense granule organization (GO:0060155) | 3.05943665 |
40 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.05781803 |
41 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.03898231 |
42 | cholesterol biosynthetic process (GO:0006695) | 3.02858211 |
43 | regulation of autophagic vacuole assembly (GO:2000785) | 3.02736196 |
44 | positive regulation of TOR signaling (GO:0032008) | 2.99607770 |
45 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.92103899 |
46 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.92103899 |
47 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.90987358 |
48 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.90987358 |
49 | cellular response to interferon-beta (GO:0035458) | 2.90767168 |
50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.90363223 |
51 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.89283234 |
52 | establishment of protein localization to mitochondrion (GO:0072655) | 2.88657501 |
53 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.87115684 |
54 | protein deneddylation (GO:0000338) | 2.87098057 |
55 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.86554081 |
56 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.85932579 |
57 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.85932579 |
58 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.85932579 |
59 | translational elongation (GO:0006414) | 2.85831038 |
60 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.83404692 |
61 | regulation of mitochondrial translation (GO:0070129) | 2.82916920 |
62 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.82457208 |
63 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.82457208 |
64 | metallo-sulfur cluster assembly (GO:0031163) | 2.82379730 |
65 | iron-sulfur cluster assembly (GO:0016226) | 2.82379730 |
66 | DNA deamination (GO:0045006) | 2.81273546 |
67 | * viral life cycle (GO:0019058) | 2.79666176 |
68 | proteasome assembly (GO:0043248) | 2.78064508 |
69 | regulation of vacuole organization (GO:0044088) | 2.78050791 |
70 | negative regulation of ligase activity (GO:0051352) | 2.77482547 |
71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.77482547 |
72 | cullin deneddylation (GO:0010388) | 2.77465328 |
73 | respiratory chain complex IV assembly (GO:0008535) | 2.76077750 |
74 | sterol biosynthetic process (GO:0016126) | 2.74877470 |
75 | GTP biosynthetic process (GO:0006183) | 2.73914352 |
76 | virion assembly (GO:0019068) | 2.72940896 |
77 | cytochrome complex assembly (GO:0017004) | 2.71710027 |
78 | ribosomal small subunit assembly (GO:0000028) | 2.71645840 |
79 | ribosomal small subunit biogenesis (GO:0042274) | 2.71127783 |
80 | protein localization to mitochondrion (GO:0070585) | 2.71075650 |
81 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.71066280 |
82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.68394610 |
83 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.68394610 |
84 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.67661527 |
85 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.66952557 |
86 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.66877939 |
87 | GPI anchor biosynthetic process (GO:0006506) | 2.66239934 |
88 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.65469472 |
89 | respiratory burst (GO:0045730) | 2.64905872 |
90 | eosinophil chemotaxis (GO:0048245) | 2.63680232 |
91 | cytidine metabolic process (GO:0046087) | 2.63522218 |
92 | cytidine catabolic process (GO:0006216) | 2.63522218 |
93 | cytidine deamination (GO:0009972) | 2.63522218 |
94 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.63493443 |
95 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.62432528 |
96 | hydrogen peroxide catabolic process (GO:0042744) | 2.61073014 |
97 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.59798221 |
98 | cellular copper ion homeostasis (GO:0006878) | 2.58129603 |
99 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.57498443 |
100 | cotranslational protein targeting to membrane (GO:0006613) | 2.57363888 |
101 | substantia nigra development (GO:0021762) | 2.55928542 |
102 | inner mitochondrial membrane organization (GO:0007007) | 2.54006337 |
103 | autophagic vacuole fusion (GO:0000046) | 2.53753591 |
104 | intracellular protein transmembrane import (GO:0044743) | 2.51939164 |
105 | cellular response to zinc ion (GO:0071294) | 2.51845855 |
106 | protein targeting to ER (GO:0045047) | 2.50355199 |
107 | ubiquinone biosynthetic process (GO:0006744) | 2.50200364 |
108 | glutathione derivative metabolic process (GO:1901685) | 2.49335102 |
109 | glutathione derivative biosynthetic process (GO:1901687) | 2.49335102 |
110 | protein localization to endoplasmic reticulum (GO:0070972) | 2.49314770 |
111 | isoprenoid biosynthetic process (GO:0008299) | 2.49301549 |
112 | actin nucleation (GO:0045010) | 2.49247061 |
113 | glutathione biosynthetic process (GO:0006750) | 2.48560933 |
114 | transferrin transport (GO:0033572) | 2.47059651 |
115 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.46987753 |
116 | cofactor catabolic process (GO:0051187) | 2.46807644 |
117 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.46015638 |
118 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.45332882 |
119 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.43770707 |
120 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.43645635 |
121 | eosinophil migration (GO:0072677) | 2.43250814 |
122 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.43147025 |
123 | copper ion homeostasis (GO:0055070) | 2.39912355 |
124 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.39864086 |
125 | regulation of metalloenzyme activity (GO:0048552) | 2.39626621 |
126 | GDP-mannose metabolic process (GO:0019673) | 2.35603412 |
127 | regulation of cellular amine metabolic process (GO:0033238) | 2.34355363 |
128 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.32116562 |
129 | GPI anchor metabolic process (GO:0006505) | 2.31232607 |
130 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.29376729 |
131 | lipoxygenase pathway (GO:0019372) | 2.29182863 |
132 | superoxide anion generation (GO:0042554) | 2.28332388 |
133 | glutathione metabolic process (GO:0006749) | 2.28278533 |
134 | ferric iron transport (GO:0015682) | 2.28161719 |
135 | trivalent inorganic cation transport (GO:0072512) | 2.28161719 |
136 | oxidative phosphorylation (GO:0006119) | 2.27395042 |
137 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.26440789 |
138 | negative regulation of acute inflammatory response (GO:0002674) | 2.25039778 |
139 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.24155982 |
140 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.23857904 |
141 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.23008320 |
142 | hydrogen peroxide metabolic process (GO:0042743) | 2.22926239 |
143 | removal of superoxide radicals (GO:0019430) | 2.20750102 |
144 | cellular response to superoxide (GO:0071451) | 2.20750102 |
145 | cellular response to oxygen radical (GO:0071450) | 2.20750102 |
146 | dopamine transport (GO:0015872) | 2.20499207 |
147 | mitochondrial transport (GO:0006839) | 2.18993832 |
148 | protein targeting to mitochondrion (GO:0006626) | 2.18372382 |
149 | cyclooxygenase pathway (GO:0019371) | 2.18117023 |
150 | dopamine biosynthetic process (GO:0042416) | 2.17683432 |
151 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.17565210 |
152 | virion attachment to host cell (GO:0019062) | 2.16070330 |
153 | adhesion of symbiont to host cell (GO:0044650) | 2.16070330 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.43678001 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.33765018 |
3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.26101316 |
4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.25358466 |
5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.16066163 |
6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.15646923 |
7 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.91728538 |
8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.81894852 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68118503 |
10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.59694135 |
11 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.56842137 |
12 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.31228951 |
13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.29364609 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.22379942 |
15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.14590706 |
16 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.03310106 |
17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.00653723 |
18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94190672 |
19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.93947048 |
20 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.91938686 |
21 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.84394094 |
22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.83104909 |
23 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80334712 |
24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.77736498 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.76882905 |
26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74429646 |
27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.73767826 |
28 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.71527956 |
29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.70119106 |
30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.69895091 |
31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69784565 |
32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.69032309 |
33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68089862 |
34 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.63344034 |
35 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.62815095 |
36 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.62181724 |
37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61812465 |
38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.61734132 |
39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.56868599 |
40 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.55219107 |
41 | * P68_20966046_ChIP-Seq_HELA_Human | 1.55126658 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53254378 |
43 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.49563661 |
44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.45761351 |
45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43894860 |
46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.43251686 |
47 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.43216776 |
48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37357435 |
49 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.36969211 |
50 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.36840048 |
51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36531406 |
52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36216289 |
53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35676711 |
54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35659445 |
55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34755099 |
56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.34228090 |
57 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.32701975 |
58 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.31957220 |
59 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.31346235 |
60 | SA1_27219007_Chip-Seq_Bcells_Human | 1.29995174 |
61 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29563999 |
62 | MAF_26560356_Chip-Seq_TH2_Human | 1.28915543 |
63 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.28623017 |
64 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28400985 |
65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.27400162 |
66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26152671 |
67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.25450076 |
68 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24419264 |
69 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.24267924 |
70 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24104836 |
71 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.24047436 |
72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23723560 |
73 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.23290418 |
74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23077549 |
75 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22996151 |
76 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22381370 |
77 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.22150023 |
78 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.21446753 |
79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20409644 |
80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19676497 |
81 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.19018663 |
82 | P300_27268052_Chip-Seq_Bcells_Human | 1.17192704 |
83 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.17001700 |
84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16971714 |
85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16971714 |
86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16299908 |
87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16253494 |
88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16229275 |
89 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12782764 |
90 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.12493677 |
91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.12187531 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12136947 |
93 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11226570 |
94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10432239 |
95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09877169 |
96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09841875 |
97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08222665 |
98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06798656 |
99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06508243 |
100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05487935 |
101 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.04889384 |
102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04127651 |
103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03532829 |
104 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02775404 |
105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02616602 |
106 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01916265 |
107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00153254 |
108 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.00030024 |
109 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99997669 |
110 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99728838 |
111 | ERA_21632823_ChIP-Seq_H3396_Human | 0.99280890 |
112 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.99246962 |
113 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99002348 |
114 | MAF_26560356_Chip-Seq_TH1_Human | 0.98760432 |
115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98301732 |
116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97259695 |
117 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.96035750 |
118 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91767282 |
119 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90543256 |
120 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.90243145 |
121 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89672647 |
122 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89383271 |
123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89236537 |
124 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87465245 |
125 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87465245 |
126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87013850 |
127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86129478 |
128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.85901602 |
129 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.85155977 |
130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84932272 |
131 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84357027 |
132 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.82311006 |
133 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81482862 |
134 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.80981501 |
135 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.80868923 |
136 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.80531993 |
137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80515955 |
138 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.79873467 |
139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79861712 |
140 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.79076915 |
141 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78744929 |
142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78303628 |
143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78189913 |
144 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.77177943 |
145 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.77125034 |
146 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76968738 |
147 | NCOR_22424771_ChIP-Seq_293T_Human | 0.75941858 |
148 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.73926653 |
149 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.73535807 |
150 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.73429006 |
151 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.73353865 |
152 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.72800849 |
153 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.72744226 |
154 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.72581444 |
155 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72343676 |
156 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.72176094 |
157 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.70967921 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003195_calcinosis | 2.82475505 |
2 | MP0002148_abnormal_hypersensitivity_rea | 2.70644938 |
3 | MP0005058_abnormal_lysosome_morphology | 2.60580495 |
4 | MP0003806_abnormal_nucleotide_metabolis | 2.57457663 |
5 | MP0003724_increased_susceptibility_to | 2.53600274 |
6 | MP0003186_abnormal_redox_activity | 2.51740512 |
7 | MP0009785_altered_susceptibility_to | 2.50317327 |
8 | MP0001529_abnormal_vocalization | 2.42811335 |
9 | MP0000920_abnormal_myelination | 2.37172988 |
10 | MP0003880_abnormal_central_pattern | 2.36563906 |
11 | MP0006082_CNS_inflammation | 2.31163439 |
12 | MP0002132_abnormal_respiratory_system | 2.27789278 |
13 | MP0008260_abnormal_autophagy | 2.26298651 |
14 | MP0010386_abnormal_urinary_bladder | 2.24294157 |
15 | MP0001905_abnormal_dopamine_level | 2.20138577 |
16 | MP0002876_abnormal_thyroid_physiology | 2.10411793 |
17 | MP0002653_abnormal_ependyma_morphology | 2.09842463 |
18 | MP0005084_abnormal_gallbladder_morpholo | 2.05915129 |
19 | MP0003136_yellow_coat_color | 1.94519681 |
20 | MP0001835_abnormal_antigen_presentation | 1.90763989 |
21 | MP0003950_abnormal_plasma_membrane | 1.90551476 |
22 | MP0003303_peritoneal_inflammation | 1.85885886 |
23 | MP0009840_abnormal_foam_cell | 1.81817506 |
24 | MP0005365_abnormal_bile_salt | 1.72254167 |
25 | MP0009379_abnormal_foot_pigmentation | 1.69218862 |
26 | MP0005000_abnormal_immune_tolerance | 1.65286947 |
27 | MP0004381_abnormal_hair_follicle | 1.63743925 |
28 | MP0005025_abnormal_response_to | 1.62825155 |
29 | MP0003329_amyloid_beta_deposits | 1.57746168 |
30 | MP0002837_dystrophic_cardiac_calcinosis | 1.56102297 |
31 | MP0003436_decreased_susceptibility_to | 1.55393034 |
32 | MP0001756_abnormal_urination | 1.53537459 |
33 | MP0004782_abnormal_surfactant_physiolog | 1.52982466 |
34 | MP0002419_abnormal_innate_immunity | 1.52195745 |
35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.50521802 |
36 | MP0004043_abnormal_pH_regulation | 1.50367442 |
37 | MP0006035_abnormal_mitochondrial_morpho | 1.48531341 |
38 | MP0002638_abnormal_pupillary_reflex | 1.44956266 |
39 | MP0003690_abnormal_glial_cell | 1.44777361 |
40 | MP0005451_abnormal_body_composition | 1.42831243 |
41 | MP0005379_endocrine/exocrine_gland_phen | 1.42748590 |
42 | MP0005310_abnormal_salivary_gland | 1.40902258 |
43 | MP0002163_abnormal_gland_morphology | 1.39209748 |
44 | MP0002295_abnormal_pulmonary_circulatio | 1.38848809 |
45 | MP0000604_amyloidosis | 1.38520464 |
46 | MP0001542_abnormal_bone_strength | 1.35874846 |
47 | MP0005166_decreased_susceptibility_to | 1.34253479 |
48 | MP0003191_abnormal_cellular_cholesterol | 1.30527480 |
49 | MP0005671_abnormal_response_to | 1.29595131 |
50 | MP0010155_abnormal_intestine_physiology | 1.29139721 |
51 | MP0006036_abnormal_mitochondrial_physio | 1.28018285 |
52 | MP0006276_abnormal_autonomic_nervous | 1.28007369 |
53 | MP0005387_immune_system_phenotype | 1.27381515 |
54 | MP0001790_abnormal_immune_system | 1.27381515 |
55 | MP0008004_abnormal_stomach_pH | 1.24042879 |
56 | MP0000372_irregular_coat_pigmentation | 1.23772422 |
57 | MP0005423_abnormal_somatic_nervous | 1.23723302 |
58 | MP0000750_abnormal_muscle_regeneration | 1.23420463 |
59 | MP0003011_delayed_dark_adaptation | 1.22336490 |
60 | MP0002796_impaired_skin_barrier | 1.21180140 |
61 | MP0004142_abnormal_muscle_tone | 1.20773565 |
62 | MP0004510_myositis | 1.19359584 |
63 | MP0005636_abnormal_mineral_homeostasis | 1.19148471 |
64 | MP0005171_absent_coat_pigmentation | 1.19137065 |
65 | MP0009764_decreased_sensitivity_to | 1.19023605 |
66 | MP0005408_hypopigmentation | 1.18613563 |
67 | MP0005174_abnormal_tail_pigmentation | 1.17643942 |
68 | MP0009333_abnormal_splenocyte_physiolog | 1.16185940 |
69 | MP0004742_abnormal_vestibular_system | 1.16019827 |
70 | MP0005083_abnormal_biliary_tract | 1.15712155 |
71 | MP0003866_abnormal_defecation | 1.15335196 |
72 | MP0005377_hearing/vestibular/ear_phenot | 1.14854208 |
73 | MP0003878_abnormal_ear_physiology | 1.14854208 |
74 | MP0001800_abnormal_humoral_immune | 1.13555279 |
75 | MP0003172_abnormal_lysosome_physiology | 1.11677197 |
76 | MP0002736_abnormal_nociception_after | 1.10381025 |
77 | MP0002139_abnormal_hepatobiliary_system | 1.10302264 |
78 | MP0008469_abnormal_protein_level | 1.10296384 |
79 | MP0005410_abnormal_fertilization | 1.08989668 |
80 | MP0001533_abnormal_skeleton_physiology | 1.08320050 |
81 | MP0002723_abnormal_immune_serum | 1.07929826 |
82 | MP0001764_abnormal_homeostasis | 1.07103122 |
83 | MP0000015_abnormal_ear_pigmentation | 1.06185047 |
84 | MP0005535_abnormal_body_temperature | 1.05520155 |
85 | MP0001986_abnormal_taste_sensitivity | 1.05462506 |
86 | MP0002277_abnormal_respiratory_mucosa | 1.05434622 |
87 | MP0005164_abnormal_response_to | 1.04552499 |
88 | MP0005332_abnormal_amino_acid | 1.04330311 |
89 | MP0009643_abnormal_urine_homeostasis | 1.03900919 |
90 | MP0005085_abnormal_gallbladder_physiolo | 1.03208445 |
91 | MP0001501_abnormal_sleep_pattern | 1.01972111 |
92 | MP0002272_abnormal_nervous_system | 1.01113568 |
93 | MP0001968_abnormal_touch/_nociception | 1.00282963 |
94 | MP0001727_abnormal_embryo_implantation | 0.99047950 |
95 | MP0004147_increased_porphyrin_level | 0.98143410 |
96 | MP0004858_abnormal_nervous_system | 0.95227748 |
97 | MP0001851_eye_inflammation | 0.94758363 |
98 | MP0001440_abnormal_grooming_behavior | 0.94526794 |
99 | MP0000538_abnormal_urinary_bladder | 0.93824037 |
100 | MP0000343_altered_response_to | 0.93271449 |
101 | MP0000685_abnormal_immune_system | 0.92581232 |
102 | MP0001346_abnormal_lacrimal_gland | 0.92123164 |
103 | MP0005319_abnormal_enzyme/_coenzyme | 0.92092501 |
104 | MP0001663_abnormal_digestive_system | 0.91934871 |
105 | MP0001845_abnormal_inflammatory_respons | 0.91594126 |
106 | MP0002405_respiratory_system_inflammati | 0.90147873 |
107 | MP0003656_abnormal_erythrocyte_physiolo | 0.89282223 |
108 | MP0005075_abnormal_melanosome_morpholog | 0.88095520 |
109 | MP0002452_abnormal_antigen_presenting | 0.88080770 |
110 | MP0002229_neurodegeneration | 0.86387530 |
111 | MP0003634_abnormal_glial_cell | 0.86094978 |
112 | MP0002090_abnormal_vision | 0.85962502 |
113 | MP0004019_abnormal_vitamin_homeostasis | 0.85129904 |
114 | MP0002909_abnormal_adrenal_gland | 0.84844247 |
115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84556157 |
116 | MP0003879_abnormal_hair_cell | 0.84392166 |
117 | MP0005464_abnormal_platelet_physiology | 0.84376458 |
118 | MP0001853_heart_inflammation | 0.82560980 |
119 | MP0003075_altered_response_to | 0.81479153 |
120 | MP0002138_abnormal_hepatobiliary_system | 0.81351880 |
121 | MP0001970_abnormal_pain_threshold | 0.81198186 |
122 | MP0005645_abnormal_hypothalamus_physiol | 0.80361059 |
123 | MP0001984_abnormal_olfaction | 0.80204363 |
124 | MP0005360_urolithiasis | 0.80042658 |
125 | MP0001819_abnormal_immune_cell | 0.79887767 |
126 | MP0002064_seizures | 0.79294653 |
127 | MP0002420_abnormal_adaptive_immunity | 0.79071097 |
128 | MP0002822_catalepsy | 0.78893910 |
129 | MP0003638_abnormal_response/metabolism_ | 0.78792589 |
130 | MP0000358_abnormal_cell_content/ | 0.78759937 |
131 | MP0005165_increased_susceptibility_to | 0.77932530 |
132 | MP0005551_abnormal_eye_electrophysiolog | 0.77932126 |
133 | MP0002095_abnormal_skin_pigmentation | 0.77904928 |
134 | MP0009765_abnormal_xenobiotic_induced | 0.77716374 |
135 | MP0009763_increased_sensitivity_to | 0.76195777 |
136 | MP0003183_abnormal_peptide_metabolism | 0.76149783 |
137 | MP0002118_abnormal_lipid_homeostasis | 0.75752179 |
138 | MP0002933_joint_inflammation | 0.74723464 |
139 | MP0000230_abnormal_systemic_arterial | 0.74720804 |
140 | MP0002136_abnormal_kidney_physiology | 0.73366985 |
141 | MP0003123_paternal_imprinting | 0.72125256 |
142 | MP0005448_abnormal_energy_balance | 0.71927318 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 5.46694558 |
2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.83924931 |
3 | Mitochondrial inheritance (HP:0001427) | 4.82572754 |
4 | Acute encephalopathy (HP:0006846) | 4.64566412 |
5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.46380064 |
6 | Progressive macrocephaly (HP:0004481) | 4.41585293 |
7 | Hepatocellular necrosis (HP:0001404) | 4.07506832 |
8 | Increased CSF lactate (HP:0002490) | 3.96815415 |
9 | Renal Fanconi syndrome (HP:0001994) | 3.88006306 |
10 | Parakeratosis (HP:0001036) | 3.87063249 |
11 | Hepatic necrosis (HP:0002605) | 3.82705390 |
12 | Increased hepatocellular lipid droplets (HP:0006565) | 3.66661586 |
13 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.65239997 |
14 | 3-Methylglutaconic aciduria (HP:0003535) | 3.43816612 |
15 | Lipid accumulation in hepatocytes (HP:0006561) | 3.41771890 |
16 | Vacuolated lymphocytes (HP:0001922) | 3.38896168 |
17 | Cerebral edema (HP:0002181) | 3.30563202 |
18 | Leukodystrophy (HP:0002415) | 3.12906576 |
19 | Neurofibrillary tangles (HP:0002185) | 3.02902296 |
20 | Increased serum pyruvate (HP:0003542) | 2.99080418 |
21 | Abnormality of glycolysis (HP:0004366) | 2.99080418 |
22 | Respiratory failure (HP:0002878) | 2.99040171 |
23 | Abnormality of renal resorption (HP:0011038) | 2.93406076 |
24 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84501667 |
25 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84501667 |
26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84501667 |
27 | Optic disc pallor (HP:0000543) | 2.84328971 |
28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.81124126 |
29 | Increased intramyocellular lipid droplets (HP:0012240) | 2.73801771 |
30 | Abnormality of macrophages (HP:0004311) | 2.66270509 |
31 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.62759641 |
32 | Lactic acidosis (HP:0003128) | 2.60484657 |
33 | Recurrent abscess formation (HP:0002722) | 2.53395824 |
34 | Testicular atrophy (HP:0000029) | 2.52864107 |
35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.51323599 |
36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.51323599 |
37 | Type I transferrin isoform profile (HP:0003642) | 2.50380582 |
38 | Increased muscle lipid content (HP:0009058) | 2.49007597 |
39 | Exercise intolerance (HP:0003546) | 2.48568592 |
40 | Axonal loss (HP:0003447) | 2.45633461 |
41 | Eczematoid dermatitis (HP:0000976) | 2.44659911 |
42 | Recurrent bacterial skin infections (HP:0005406) | 2.43952220 |
43 | Increased IgM level (HP:0003496) | 2.39538793 |
44 | Abnormality of urine glucose concentration (HP:0011016) | 2.39028231 |
45 | Glycosuria (HP:0003076) | 2.39028231 |
46 | Exertional dyspnea (HP:0002875) | 2.38276357 |
47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36789312 |
48 | Hepatosplenomegaly (HP:0001433) | 2.35259914 |
49 | Increased serum lactate (HP:0002151) | 2.31840206 |
50 | Hypothermia (HP:0002045) | 2.26040965 |
51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25916052 |
52 | Polyphagia (HP:0002591) | 2.25449442 |
53 | Cerebral hemorrhage (HP:0001342) | 2.24649887 |
54 | Prolonged neonatal jaundice (HP:0006579) | 2.22522238 |
55 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.16763567 |
56 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.15578344 |
57 | Neuroendocrine neoplasm (HP:0100634) | 2.15351989 |
58 | Abnormal number of erythroid precursors (HP:0012131) | 2.15183303 |
59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.07822494 |
60 | Pheochromocytoma (HP:0002666) | 2.05137792 |
61 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.03424623 |
62 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.03424623 |
63 | Sensory axonal neuropathy (HP:0003390) | 2.02853438 |
64 | Cerebral palsy (HP:0100021) | 2.01405030 |
65 | Abnormal protein glycosylation (HP:0012346) | 2.00083974 |
66 | Abnormal glycosylation (HP:0012345) | 2.00083974 |
67 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00083974 |
68 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00083974 |
69 | Cerebral inclusion bodies (HP:0100314) | 2.00024765 |
70 | Myositis (HP:0100614) | 1.99486380 |
71 | Lethargy (HP:0001254) | 1.99331951 |
72 | Hyperphosphaturia (HP:0003109) | 1.97390451 |
73 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96413724 |
74 | Obstructive lung disease (HP:0006536) | 1.96413724 |
75 | Systemic lupus erythematosus (HP:0002725) | 1.96009245 |
76 | CNS demyelination (HP:0007305) | 1.95033860 |
77 | Nausea (HP:0002018) | 1.94183651 |
78 | Respiratory difficulties (HP:0002880) | 1.91467908 |
79 | Muscle fiber atrophy (HP:0100295) | 1.91265674 |
80 | Erythroderma (HP:0001019) | 1.90547113 |
81 | Autoamputation (HP:0001218) | 1.89892658 |
82 | Cholecystitis (HP:0001082) | 1.89504124 |
83 | Abnormal gallbladder physiology (HP:0012438) | 1.89504124 |
84 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89340567 |
85 | X-linked dominant inheritance (HP:0001423) | 1.88828525 |
86 | Generalized aminoaciduria (HP:0002909) | 1.88102813 |
87 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.88074115 |
88 | Abnormal pupillary function (HP:0007686) | 1.87595199 |
89 | Purpura (HP:0000979) | 1.86727874 |
90 | Renal tubular dysfunction (HP:0000124) | 1.84599910 |
91 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84304675 |
92 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.83736398 |
93 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.83736398 |
94 | Prolonged partial thromboplastin time (HP:0003645) | 1.83494021 |
95 | Progressive neurologic deterioration (HP:0002344) | 1.76800434 |
96 | Reduced antithrombin III activity (HP:0001976) | 1.76518533 |
97 | Hypokinesia (HP:0002375) | 1.74670863 |
98 | Mesangial abnormality (HP:0001966) | 1.74305258 |
99 | Abnormal ciliary motility (HP:0012262) | 1.73808706 |
100 | Methylmalonic aciduria (HP:0012120) | 1.72363803 |
101 | Spastic paraparesis (HP:0002313) | 1.72331150 |
102 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72174118 |
103 | Methylmalonic acidemia (HP:0002912) | 1.70757225 |
104 | Nasal polyposis (HP:0100582) | 1.69473580 |
105 | Amniotic constriction ring (HP:0009775) | 1.68574760 |
106 | Abnormality of placental membranes (HP:0011409) | 1.68574760 |
107 | Progressive microcephaly (HP:0000253) | 1.68488250 |
108 | Abnormal urine phosphate concentration (HP:0012599) | 1.68375010 |
109 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.67624555 |
110 | Medial flaring of the eyebrow (HP:0010747) | 1.66190847 |
111 | Stomatitis (HP:0010280) | 1.65451711 |
112 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.65278553 |
113 | Vomiting (HP:0002013) | 1.63672325 |
114 | Cholelithiasis (HP:0001081) | 1.62555798 |
115 | Ragged-red muscle fibers (HP:0003200) | 1.62115687 |
116 | Orchitis (HP:0100796) | 1.61982988 |
117 | Myopathic facies (HP:0002058) | 1.60464336 |
118 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.59903759 |
119 | Loss of speech (HP:0002371) | 1.59413682 |
120 | Hypergammaglobulinemia (HP:0010702) | 1.58352160 |
121 | Increased cerebral lipofuscin (HP:0011813) | 1.58018988 |
122 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.57427712 |
123 | Dicarboxylic aciduria (HP:0003215) | 1.57427712 |
124 | Macrocytic anemia (HP:0001972) | 1.55290236 |
125 | Paralysis (HP:0003470) | 1.54946434 |
126 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.54897318 |
127 | Cerebral hypomyelination (HP:0006808) | 1.54623824 |
128 | Recurrent skin infections (HP:0001581) | 1.51850665 |
129 | Emotional lability (HP:0000712) | 1.51814872 |
130 | Dysostosis multiplex (HP:0000943) | 1.49121997 |
131 | Petechiae (HP:0000967) | 1.48068313 |
132 | Hypomagnesemia (HP:0002917) | 1.45869770 |
133 | Blindness (HP:0000618) | 1.44860636 |
134 | Patchy hypopigmentation of hair (HP:0011365) | 1.44776033 |
135 | Steatorrhea (HP:0002570) | 1.43953557 |
136 | Abnormality of magnesium homeostasis (HP:0004921) | 1.42416607 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 4.05860280 |
2 | MST4 | 3.77353433 |
3 | VRK2 | 3.70912833 |
4 | ARAF | 3.33103136 |
5 | STK39 | 3.28454077 |
6 | MAP3K12 | 2.65171331 |
7 | MAP3K11 | 2.51823679 |
8 | BCR | 2.35212310 |
9 | NME2 | 2.32188421 |
10 | OXSR1 | 2.27803473 |
11 | STK16 | 2.25586340 |
12 | MYLK | 2.02053229 |
13 | GRK7 | 1.99398907 |
14 | BMPR2 | 1.93575915 |
15 | MAP3K14 | 1.87935770 |
16 | NME1 | 1.84351860 |
17 | LIMK1 | 1.78517031 |
18 | WNK4 | 1.76678128 |
19 | EPHB1 | 1.73619414 |
20 | MAPKAPK5 | 1.73046484 |
21 | PIM2 | 1.70244332 |
22 | RIPK4 | 1.65921138 |
23 | BLK | 1.62193087 |
24 | ERN1 | 1.59024320 |
25 | LRRK2 | 1.48654432 |
26 | GRK6 | 1.42028069 |
27 | EPHB2 | 1.41135524 |
28 | MAPKAPK3 | 1.35734803 |
29 | MET | 1.33801273 |
30 | CASK | 1.33663730 |
31 | IRAK3 | 1.31566255 |
32 | IRAK4 | 1.31475628 |
33 | TBK1 | 1.28464714 |
34 | TESK1 | 1.27702300 |
35 | BRAF | 1.27626259 |
36 | MAP2K2 | 1.23907451 |
37 | TAOK1 | 1.21622361 |
38 | BMPR1B | 1.21061544 |
39 | PIK3CG | 1.19360617 |
40 | PKN1 | 1.17565198 |
41 | GRK5 | 1.17206571 |
42 | MUSK | 1.14521275 |
43 | CAMK2B | 1.13401109 |
44 | MAP4K1 | 1.12266993 |
45 | TAOK2 | 1.10085721 |
46 | LMTK2 | 1.09880945 |
47 | IKBKB | 1.08186099 |
48 | TXK | 1.07983523 |
49 | ADRBK2 | 1.07241188 |
50 | IKBKE | 1.04942373 |
51 | CAMK2D | 1.04006751 |
52 | FGR | 1.03716096 |
53 | TESK2 | 1.01546267 |
54 | TNK2 | 1.00491962 |
55 | CAMK2G | 1.00284616 |
56 | CSK | 0.99078249 |
57 | MAP2K6 | 0.97343332 |
58 | EPHA2 | 0.96991802 |
59 | MAPK15 | 0.94833670 |
60 | ABL2 | 0.90126347 |
61 | BCKDK | 0.89096578 |
62 | PINK1 | 0.87283009 |
63 | MST1R | 0.86909228 |
64 | PRKCE | 0.86535192 |
65 | CSNK1G3 | 0.86432444 |
66 | MAP3K13 | 0.82170233 |
67 | DAPK1 | 0.82148326 |
68 | MAP4K2 | 0.80965550 |
69 | EPHA3 | 0.80199852 |
70 | DYRK2 | 0.78162619 |
71 | FES | 0.77553505 |
72 | KDR | 0.74747183 |
73 | NEK6 | 0.74512176 |
74 | PRKD2 | 0.73846027 |
75 | RPS6KA5 | 0.72965070 |
76 | DAPK3 | 0.72676910 |
77 | PRKCQ | 0.69803582 |
78 | CDK19 | 0.69298620 |
79 | VRK1 | 0.68761694 |
80 | CAMK2A | 0.67655738 |
81 | IRAK1 | 0.65298614 |
82 | DYRK3 | 0.64369378 |
83 | PHKG1 | 0.64231316 |
84 | PHKG2 | 0.64231316 |
85 | ROCK2 | 0.63889928 |
86 | PRKCD | 0.62443472 |
87 | MOS | 0.61036065 |
88 | PAK4 | 0.56742303 |
89 | TRPM7 | 0.56733715 |
90 | ZAP70 | 0.56520230 |
91 | ADRBK1 | 0.56481320 |
92 | SYK | 0.55896355 |
93 | EIF2AK1 | 0.55830929 |
94 | AKT3 | 0.55346653 |
95 | ILK | 0.55195176 |
96 | OBSCN | 0.54937036 |
97 | NTRK1 | 0.54485585 |
98 | EIF2AK3 | 0.53881069 |
99 | GRK1 | 0.52995589 |
100 | DAPK2 | 0.52805717 |
101 | PLK2 | 0.52341923 |
102 | MAP3K2 | 0.52097854 |
103 | MAP2K7 | 0.52055122 |
104 | PRKD1 | 0.50953753 |
105 | PRKCI | 0.50061539 |
106 | PTK2B | 0.49653024 |
107 | CSNK1G1 | 0.49094282 |
108 | PDK2 | 0.49010161 |
109 | LCK | 0.47716529 |
110 | ZAK | 0.47555791 |
111 | AURKA | 0.46345663 |
112 | LYN | 0.46278053 |
113 | TIE1 | 0.44789583 |
114 | MAP3K3 | 0.43966913 |
115 | DYRK1B | 0.43827459 |
116 | TNIK | 0.43494424 |
117 | PRKG2 | 0.43247924 |
118 | PRKACA | 0.42160854 |
119 | SIK2 | 0.41336834 |
120 | MAP2K1 | 0.40215564 |
121 | SIK3 | 0.39756273 |
122 | TYK2 | 0.39734433 |
123 | MAP3K5 | 0.39476818 |
124 | TEC | 0.39424110 |
125 | IRAK2 | 0.38635387 |
126 | MATK | 0.38493886 |
127 | MAP2K3 | 0.38445118 |
128 | CSNK1A1L | 0.35697390 |
129 | PAK3 | 0.35105726 |
130 | TAOK3 | 0.34492551 |
131 | PAK1 | 0.33850142 |
132 | ERBB3 | 0.33706822 |
133 | CSNK2A2 | 0.33533113 |
134 | CDK14 | 0.33146733 |
135 | TLK1 | 0.32911083 |
136 | PRKCA | 0.32439160 |
137 | CSNK1G2 | 0.29971809 |
138 | CSNK2A1 | 0.29929416 |
139 | MAP3K1 | 0.29224979 |
140 | BUB1 | 0.29182250 |
141 | BTK | 0.27309226 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.31387321 |
2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.11315160 |
3 | Protein export_Homo sapiens_hsa03060 | 3.43041104 |
4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.30457857 |
5 | Proteasome_Homo sapiens_hsa03050 | 3.13880917 |
6 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.86789762 |
7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.72765001 |
8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.48596972 |
9 | Ribosome_Homo sapiens_hsa03010 | 2.46789141 |
10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.43996379 |
11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.43738142 |
12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.29293952 |
13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.16254497 |
14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.04451659 |
15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.94831836 |
16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.75316821 |
17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.75220597 |
18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.69274545 |
19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.69167353 |
20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.47170215 |
21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43873603 |
22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.43252102 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35873107 |
24 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.31952016 |
25 | RNA polymerase_Homo sapiens_hsa03020 | 1.28323835 |
26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.22127569 |
27 | Phagosome_Homo sapiens_hsa04145 | 1.19469777 |
28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.17116881 |
29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.15149101 |
30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14643282 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13402351 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13302939 |
33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12925723 |
34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.11974199 |
35 | Allograft rejection_Homo sapiens_hsa05330 | 1.10809468 |
36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09091875 |
37 | Lysosome_Homo sapiens_hsa04142 | 1.08417127 |
38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04881631 |
39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04347491 |
40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.03937892 |
41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03761472 |
42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02715985 |
43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01807911 |
44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00829595 |
45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00760902 |
46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.00004532 |
47 | Peroxisome_Homo sapiens_hsa04146 | 0.98109845 |
48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.97677746 |
49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.95232501 |
50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93665468 |
51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93389369 |
52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91047183 |
53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89286207 |
54 | Asthma_Homo sapiens_hsa05310 | 0.88000643 |
55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87615772 |
56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87339580 |
57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81274608 |
58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80667795 |
59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78208402 |
60 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75865787 |
61 | Pertussis_Homo sapiens_hsa05133 | 0.74571177 |
62 | Shigellosis_Homo sapiens_hsa05131 | 0.73496109 |
63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71718848 |
64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70239347 |
65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.69798286 |
66 | Mineral absorption_Homo sapiens_hsa04978 | 0.69122141 |
67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68926870 |
68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68010491 |
69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67430514 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65098586 |
71 | Legionellosis_Homo sapiens_hsa05134 | 0.63623277 |
72 | Malaria_Homo sapiens_hsa05144 | 0.61807867 |
73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61221486 |
74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57778800 |
75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56798011 |
76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.55414487 |
77 | Salmonella infection_Homo sapiens_hsa05132 | 0.55035937 |
78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54873235 |
79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53853626 |
80 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53835458 |
81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51988217 |
82 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51987348 |
83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51760553 |
84 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.51622849 |
85 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51531589 |
86 | Base excision repair_Homo sapiens_hsa03410 | 0.50885134 |
87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50872261 |
88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48872517 |
89 | Phototransduction_Homo sapiens_hsa04744 | 0.47589047 |
90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46771176 |
91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45820001 |
92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45548866 |
93 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.43614242 |
94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41544185 |
95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41483796 |
96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39243285 |
97 | Leishmaniasis_Homo sapiens_hsa05140 | 0.37952802 |
98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37897434 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.36772891 |
100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33387732 |
101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31900882 |
102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.31649520 |
103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31155682 |
104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.30880723 |
105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.30391052 |
106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.30030765 |
107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29961338 |
108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29897444 |
109 | Tuberculosis_Homo sapiens_hsa05152 | 0.28513615 |
110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27592415 |
111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.27389871 |
112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27115236 |
113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24252321 |
114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.23053712 |
115 | Purine metabolism_Homo sapiens_hsa00230 | 0.22899350 |
116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.22734419 |
117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21130369 |
118 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.18232807 |
119 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.16432617 |